Matthew Davis

11.1k citations
79 papers · 8.1k · 5 hit papers · h-index 24

Impact in

Papers in

Matthew Davis

73 papers receiving 7.8k citations

Matthew Davis's Hit Papers

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons 2024 · 117 citations
1170+7+15Years since publication10002.0k3.0k

Peers

Matthew Davis
Comparison fields: 5 of 135
  • Ophthalmology 2.1k
  • Endocrinology, Diabetes and Metabolism 2.8k
  • Radiology, Nuclear Medicine and Imaging 1.2k
  • Pharmacology 628
  • Nephrology 205
Replace Robert E. J. Ryder with:
Robert E. J. Ryder United Kingdom
Weiming Mao United States
Jonathan C. Javitt United States
George Cotsonis United States
CHRISANDRA L. SHUFELT United States
David J. Ramsey United States
Fang Yao Tang China
Jianjiang Xu China
A. Titia Lely Netherlands
Anselm J. M. Hennis United States
Matthew Davis relative to Robert E. J. Ryder United Kingdom Robert E. J. Ryder's profile →
Citations per field
00.5×5×10.7×
Robert E. J. Ryder · 1×
Citations per year

Countries citing papers authored by Matthew Davis

Since Specialization
Citations

This map shows the geographic impact of Matthew Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Davis more than expected).

Fields of papers citing papers by Matthew Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Davis. The network helps show where Matthew Davis may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Davis Line = papers co-authored together Matthew Davis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales
Hit paper breakdown →
20033002
2
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hit paper breakdown →
20192307
3
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Hit paper breakdown →
2017653
4
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hit paper breakdown →
2019492
5 2018167
6 2010149
7 1997134
8
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
Hit paper breakdown →
2024117
9 2013114
10 202295
11 202192
12 201873
13 201251
14 202047
15 201846
16 202341
17 202340
18 201635
19 202031
20 199428

About Matthew Davis

Matthew Davis is a scholar working on Gender Studies, Ophthalmology, Infectious Diseases, Epidemiology and Oncology, having authored 79 papers that have together received 8.1k indexed citations. Recurring topics across this work include Respiratory viral infections research (9 papers), Diversity and Career in Medicine (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Retinal Diseases and Treatments (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Advances in Oncology and Radiotherapy (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Diabetes Treatment and Management (3 papers). The work is most often cited by research in Ophthalmology (2.1k citations), Endocrinology, Diabetes and Metabolism (2.8k citations), Radiology, Nuclear Medicine and Imaging (1.2k citations), Pharmacology (628 citations) and Nephrology (205 citations). Matthew Davis has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Juan Verdaguer, C. P. Wilkinson, Diana G. Dills, Paul P. Lee, Frederick L. Ferris, Ronald Klein, Anselm Kampik, Ramachandra Pararajasegaram, Miguel Ángel Cano and Linda G. Castillo. Their work appears in journals such as Plastic & Reconstructive Surgery, Diabetes Care, Open Forum Infectious Diseases, Clinical Infectious Diseases and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact